Childhood Asthma in Urban Settings Clinical Research Network
- Award ceiling
- Not stated
- Closes
- Not stated
- Last verified
- 2026-10-28
Per-recipient award not stated for city or township governments, county governments, for profit organizations other than small businesses, independent school districts, native american tribal governments (federally recognized), native american tribal organizations (other than federally recognized tribal governments), nonprofits having a 501(c)(3) status with the irs, other than institutions of higher education, nonprofits that do not have a 501(c)(3) status with the irs, other than institutions of higher education, others (see text field entitled "additional information on eligibility" for clarification), private institutions of higher education, public and state controlled institutions of higher education, public housing authorities/indian housing authorities, small businesses, special district governments, state governments.
City or township governmentsCounty governmentsFor profit organizations other than small businessesIndependent school districtsNative American tribal governments (Federally recognized)Native American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationOthers (see text field entitled "Additional Information on Eligibility" for clarification)Private institutions of higher educationPublic and State controlled institutions of higher educationPublic housing authorities/Indian housing authoritiesSmall businessesSpecial district governmentsState governmentsHealth & Human Services
In one sentence
Childhood Asthma in Urban Settings Clinical Research Network does not state a per-recipient award amount, open to city or township governments, county governments, for profit organizations other than small businesses, independent school districts, native american tribal governments (federally…
Record fields
- Program pool (total)
- $8,380,000Total across all awards in this programme. Not an amount any single applicant can receive.
- Award ceiling (per project)
- Not confirmed
- Award floor
- Not confirmed
- Typical award
- Not confirmed
- Deadline
- Not stated
- Deadline type
- Not stated
- Opens
- Jan 8, 2027
- Status
- Forecasted
- Eligible entities
- City or township governments · County governments · For profit organizations other than small businesses · Independent school districts · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Private institutions of higher education · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · Small businesses · Special district governments · State governments
- Geography
- Not stated
- Matching funds
- No
- Disbursement
- Not confirmed
- Application effort
- Not confirmed
- Use of funds
- development and testing of innovative hypotheses and strategies for asthma prevention · identification and testing of new treatment targets for asthma · exploration of risk relationship between upper and lower airway · identification of disease endotypes suitable for therapeutic modalities
- Currency
- USD
How much money is available?
Two different figures govern a programme and they are not interchangeable. The programme pool is what the funder has allocated across every award it will make this cycle. The award ceiling is the most one applicant can be granted.
Program pool (total)Across all awards this cycle
$8,380,000Award ceiling (per project)The most one applicant can receive
Not statedWho can apply?
level
Derived from the source that published this record
entity
City or township governments, County governments, For profit organizations other than small businesses, Independent school districts, Native American tribal governments (Federally recognized), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Others (see text field entitled "Additional Information on Eligibility" for clarification), Private institutions of higher education
Source field: entity types+5more
, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, Small businesses, Special district governments, State governmentsindustry
Source field: industries
demographic
pediatric populations
Source field: demographicsuse
development and testing of innovative hypotheses and strategies for asthma prevention, exploration of risk relationship between upper and lower airway, identification and testing of new treatment targets for asthma, identification of disease endotypes suitable for therapeutic modalities
Source field: use of fundssize limit
Not confirmed
Source field: applicant size limitclause text
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional…
We store the structured fields above. Clause-by-clause text from the guidelines is not connected for this record.When does it close?
Not statedDeadline type Not stated
What can the money be used for?
4 categorysThe source’s own spending categories, and what is not parsed.
development and testing of innovative hypotheses and strategies for asthma preventionidentification and testing of new treatment targets for asthmaexploration of risk relationship between upper and lower airwayidentification of disease endotypes suitable for therapeutic modalities
These categories come from the source's own classification. A line-item cost table, where the programme publishes one, lives in the guidelines and is not parsed for this record.
How hard is the application?
1 fieldEffort, match requirement and reimbursement, as the source stated them.
- Application effort
- Not confirmed
- Disbursement
- Not confirmed
- Matching funds
- No
Who has received this funding?
15561 awardsAwards on file for this programme, counted rather than modelled.
15561 prior awards on file for this programme, largest first. Every row comes from the funder's own award listing; nothing here is estimated.
| Recipient | State | Amount | Fiscal year |
|---|---|---|---|
| FIMBRION THERAPEUTICS INC | Not stated | $600,000 | 2023 |
| HARLINGENE LIFE SCIENCES LLC | Not stated | $600,000 | 2023 |
| IMMPORT THERAPEUTICS INC | Not stated | $600,000 | 2020 |
| INTEGRATED BIOTHERAPEUTICS, LLC | Not stated | $600,000 | 2019 |
| INTEGRATED BIOTHERAPEUTICS, LLC | Not stated | $600,000 | 2019 |
| KEPHERA DIAGNOSTICS LLC | Not stated | $600,000 | 2023 |
| KEPHERA DIAGNOSTICS LLC | Not stated | $600,000 | 2019 |
| LUNA BIOSCIENCE, INC. | Not stated | $600,000 | 2023 |
| MICROBIOTIX, INC. | Not stated | $600,000 | 2020 |
| MICROBIOTIX, INC. | Not stated | $600,000 | 2018 |
| MICROBIOTIX, INC. | Not stated | $600,000 | 2024 |
| MONTANA MOLECULAR LLC | Not stated | $600,000 | 2022 |
| NEOCHROMOSOME, INC. | Not stated | $600,000 | 2020 |
| OPTIMEOS LIFE SCIENCES, INC. | Not stated | $600,000 | 2025 |
| ORLANCE, INC | Not stated | $600,000 | 2024 |
| OYAGEN, INC. | Not stated | $600,000 | 2023 |
| PHAST CORP | Not stated | $600,000 | 2019 |
| PLANET BIOTECHNOLOGY INCORPORATED | Not stated | $600,000 | 2024 |
| PLANET BIOTECHNOLOGY INCORPORATED | Not stated | $600,000 | 2023 |
| PLEX PHARMACEUTICALS INC | Not stated | $600,000 | 2020 |
| POP BIOTECHNOLOGIES INC | Not stated | $600,000 | 2024 |
| QENTOROS LLC | Not stated | $600,000 | 2023 |
| QUERCUS MOLECULAR DESIGN, LLC | Not stated | $600,000 | 2022 |
| SANARIA INC. | Not stated | $600,000 | 2022 |
| SANARIA INC. | Not stated | $600,000 | 2020 |
| TECHIMMUNE LLC | Not stated | $600,000 | 2023 |
| TENDEL THERAPIES INC. | Not stated | $600,000 | 2022 |
| VENATORX PHARMACEUTICALS INC | Not stated | $600,000 | 2023 |
| VIRONIKA LLC | Not stated | $600,000 | 2021 |
| VIRONIKA LLC | Not stated | $600,000 | 2019 |
| VIRONIKA LLC | Not stated | $600,000 | 2018 |
| ZYLO THERAPEUTICS, INC. | Not stated | $600,000 | 2025 |
| FOX CHASE CHEMICAL DIVERSITY CENTER INC. | Not stated | $599,999 | 2020 |
| HAFION INC. | Not stated | $599,999 | 2022 |
| IMMPORT THERAPEUTICS INC | Not stated | $599,999 | 2020 |
| IREX PHARMA LLC | Not stated | $599,999 | 2019 |
| CHICAGO BIOSOLUTIONS INC | Not stated | $599,998 | 2019 |
| PLANET BIOTECHNOLOGY INCORPORATED | Not stated | $599,998 | 2024 |
| SANARIA INC. | Not stated | $599,998 | 2018 |
| KEPHERA DIAGNOSTICS LLC | Not stated | $599,996 | 2020 |
| SANARIA INC. | Not stated | $599,994 | 2020 |
| POP BIOTECHNOLOGIES INC | Not stated | $599,982 | 2021 |
| CHROMOLOGIC LLC | Not stated | $599,979 | 2021 |
| LYCHEE BIOSCIENCE LLC | Not stated | $599,970 | 2024 |
| INNOVATION PATHWAYS, LLC | Not stated | $599,969 | 2018 |
| L2 DIAGNOSTICS LLC | Not stated | $599,954 | 2025 |
| SANARIA INC. | Not stated | $599,951 | 2023 |
| L2 DIAGNOSTICS LLC | Not stated | $599,938 | 2024 |
| RAFT PHARMACEUTICALS LLC | Not stated | $599,929 | 2019 |
| MABDX | Not stated | $599,913 | 2021 |
| NUBAD LLC | Not stated | $599,880 | 2016 |
| L2 DIAGNOSTICS LLC | Not stated | $599,866 | 2024 |
| HILLHURST BIOPHARMACEUTICALS, INC. | Not stated | $599,788 | 2022 |
| VITALEX BIOSCIENCES, LLC | Not stated | $599,748 | 2018 |
| CALDER BIOSCIENCES INC. | Not stated | $599,742 | 2018 |
| L2 DIAGNOSTICS LLC | Not stated | $599,709 | 2025 |
| KEPHERA DIAGNOSTICS LLC | Not stated | $599,658 | 2019 |
| LARIX BIOSCIENCE LLC | Not stated | $599,638 | 2023 |
| LUNA BIOSCIENCE, INC. | Not stated | $599,631 | 2024 |
| BIOPEPTIDES CORP | Not stated | $599,624 | 2019 |
| MOLECULAR EXPRESS, INC | Not stated | $599,596 | 2022 |
| CHEMITOPE GLYCOPEPTIDE INC | Not stated | $599,591 | 2019 |
| BCN BIOSCIENCES LLC | Not stated | $599,525 | 2019 |
| LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | Not stated | $599,500 | 2015 |
| MICROBIOTIX, INC. | Not stated | $599,449 | 2020 |
| MICROBIOTIX, INC. | Not stated | $599,327 | 2025 |
| KEPHERA DIAGNOSTICS LLC | Not stated | $599,308 | 2018 |
| CHICAGO BIOSOLUTIONS INC | Not stated | $599,262 | 2021 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | Not stated | $599,147 | 2021 |
| L2 DIAGNOSTICS LLC | Not stated | $599,028 | 2021 |
| HASENTECH, INC. | Not stated | $598,945 | 2024 |
| PNEUMOTACTIX, LLC | Not stated | $598,900 | 2021 |
| ASTERO ERADO INC | Not stated | $598,849 | 2023 |
| ORLANCE, INC | Not stated | $598,837 | 2025 |
| ALBERT EINSTEIN COLLEGE OF MEDICINE | Not stated | $598,752 | 2024 |
| ALBERT EINSTEIN COLLEGE OF MEDICINE | Not stated | $598,752 | 2024 |
| NUBAD LLC | Not stated | $598,579 | 2022 |
| BIOLOGICAL MIMETICS, INC. | Not stated | $598,436 | 2020 |
| INTEGRATED BIOTHERAPEUTICS, LLC | Not stated | $598,258 | 2019 |
| FOX CHASE CHEMICAL DIVERSITY CENTER INC. | Not stated | $598,124 | 2022 |
| INBIOS INTERNATIONAL INC | Not stated | $598,047 | 2020 |
| SCIOGEN LLC | Not stated | $597,985 | 2020 |
| TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER AT EL PASO | Not stated | $597,817 | 2021 |
| FOX CHASE CHEMICAL DIVERSITY CENTER INC. | Not stated | $597,797 | 2020 |
| QUERCUS MOLECULAR DESIGN, LLC | Not stated | $597,725 | 2023 |
| MICROBIOTIX, INC. | Not stated | $597,627 | 2018 |
| L2 DIAGNOSTICS LLC | Not stated | $597,612 | 2024 |
| FOX CHASE CHEMICAL DIVERSITY CENTER INC. | Not stated | $597,435 | 2018 |
| ACEPRE, LLC | Not stated | $597,310 | 2023 |
| COMPUTER TECHNOLOGY ASSOCIATES, INC. | Not stated | $597,223 | 2022 |
| FLORIDA INTERNATIONAL UNIVERSITY | Not stated | $597,184 | 2020 |
| KATHERA BIOSCIENCE INC | Not stated | $597,060 | 2023 |
| TENGEN BIOMEDICAL CO | Not stated | $597,060 | 2022 |
| OYAGEN, INC. | Not stated | $597,000 | 2023 |
| LUMEN BIOSCIENCE, INC | Not stated | $596,975 | 2018 |
| BESSOR PHARMA, LLC | Not stated | $596,930 | 2023 |
| PLANET BIOTECHNOLOGY INCORPORATED | Not stated | $596,920 | 2024 |
| ZENVAX LLC | Not stated | $596,842 | 2025 |
| MICROBIOTIX, INC. | Not stated | $596,806 | 2020 |
| TRAVERSE BIOTECH II INC | Not stated | $596,655 | 2024 |
Recipient names as published by the California Grants Portal.
What comparable notices state
294 recordsStated ceilings on open records in the same industry.
Among open records stored under Health & Human Services, 294 of 889 state an award ceiling. Those that do run:
- 25th percentile$353,750
- Median$600,000
- 75th percentile$1,500,000
A statistical estimate, not a prediction. It describes what a set of notices has published in this catalogue on the day you read it, and says nothing about what this programme will award. Records stating no ceiling are excluded rather than counted as zero, and the programme pool — what a funder has across every applicant — is a different column and is never mixed in.
Who has won this programme before?
15561 awardsAwards under the same assistance listing, not under this notice.
15561 federal awards on file under assistance listing 93.855, the programme this notice is published under. These are not awards made under this notice — a listing covers every year the programme runs, and awards under an open notice do not exist yet.
- $1,073,967,938FRED HUTCHINSON CANCER CENTERWA · FY2006
- $246,626,852PRESIDENT AND FELLOWS OF HARVARD COLLEGEMA · FY2006
- $201,437,825SCRIPPS RESEARCH INSTITUTECA · FY2019
- $197,316,803UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTONTX · FY2011
- $180,737,624DUKE UNIVERSITYNC · FY2013
Common questions
5 questionsEvery answer is a stored field from this record. Questions the source did not answer are not asked.
- How much funding is available in total?
- $8,380,000 across the whole programme. This is the total the funder has allocated, not an amount any single applicant can receive.
- Who is eligible to apply?
- City or township governments, County governments, For profit organizations other than small businesses, Independent school districts, Native American tribal governments (Federally recognized), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Others (see text field entitled "Additional Information on Eligibility" for clarification), Private institutions of higher education, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, Small businesses, Special district governments, State governments.
- What can the funding be used for?
- development and testing of innovative hypotheses and strategies for asthma prevention, identification and testing of new treatment targets for asthma, exploration of risk relationship between upper and lower airway, identification of disease endotypes suitable for therapeutic modalities, as classified by the source.
- Is matching funding required?
- No. The source states that no matching funds are required.
- Has this programme funded anyone before?
- 15561 prior awards are on file for this programme, made by National Institutes of Health. Recipients, amounts and fiscal years are listed on this page.
AI summary of the source text
Optional. Every core field on this record is already above, free and complete.
AI summary of the source text
Studio reads this record’s stored eligibility and materials text and breaks it into separate points, each quoting the exact words it came from. It never writes application prose, never guesses at a field the source did not state, and never estimates anyone’s chances.
Included with Studio
Sign inWhat else is open
Also open from National Institutes of Health
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)Closes Not statedAwards Not stated
- Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)Closes Not statedAwards Not stated
- Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)Closes Oct 11, 2029Awards Not stated
- Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)Closes Nov 10, 2026Awards $50,000 – $100,000
- NEI Center Core Grant for Vision Research (P30 Clinical Trial Not Allowed)Closes Not statedAwards Not stated
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)Closes Not statedAwards Not stated
Also open under assistance listing 93.855
A listing names the programme; a notice names one round of it. These are other rounds open now, not other years of this one.
- NIH Research Program Projects (Parent P01 Clinical Trial Optional)Closes May 25, 2029Awards Not stated
- Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)Closes May 28, 2027Awards up to $3,500,000
- Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)Closes Jun 20, 2029Awards Not stated
- Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)Closes May 25, 2029Awards Not stated
- Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)Closes Oct 19, 2027Awards up to $650,000
- NIH Research Project Grant (Parent R01 Clinical Trial Required)Closes Jan 7, 2028Awards Not stated
Provenance
Source pagegrants.gov
Retrieved2026-10-28
MethodAutomated check
First seen2026-09-06
Assistance listing93.855
The official page governs. If the source and this record disagree, the source is correct — programmes change their terms between our checks, so confirm every figure above before you apply.